多学科心脏团队对风险最高的门疾病的见解
Taylor Pickering1, John Eisenga1, Kyle McCullough1
1Baylor Scott & White Research Institute, Plano, Texas, USA.
概括
多学科心脏团队 (MHT) 评估指导复杂的膜心脏病 (VHD) 患者的治疗. 这种方法有助于选择适当的干预措施,改善高风险个体的结果.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 建议对复杂的膜心脏病 (VHD) 进行多学科心脏团队 (MHT) 评估.
- 对于接受手术转诊的高风险VHD患者,结果数据有限.
- 医疗保健医院集成了各种各样的专家进行全面的患者评估.
研究的目的:
- 分析机构MHT评估的高风险或复杂VHD患者的结果.
- 评估MHT建议对患者管理和生存的影响.
主要方法:
- 从2021年6月到2022年8月对121名高风险/复杂VHD患者的前性评估.
- MHT包括心脏外科医生,干预性心脏病学家,心力衰竭专家,成像学家,重症治疗师和息治疗师.
- 收集的数据:人口统计,风险评分,治疗计划,MHT建议,坚持,再录取和30天,1年和2年的死亡率.
主要成果:
- 在67%的患者中,MHT建议进行手术,在14%的患者中进行过导管干预,在3%的患者中进行混合治疗,在17%的患者中进行医疗管理.
- 总体上,MHT建议的遵守率为89%.
- 两年死亡率有所不同:手术21%,透导管53%,混合33%,医疗管理55%.
结论:
- 通过MHT评估,可以为复杂的VHD制定个性化治疗策略.
- 它确定了那些尽管存在高风险,但从干预中受益的患者.
- 它还节省了那些不太可能从激进治疗中受益的患者.
相关概念视频
Mitral Stenosis IV: Nursing Management
355
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
355
Mitral Valve Prolapse II: Assessment and Management
982
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
982
Mitral Stenosis III: Medical Management
422
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
422
Mitral Regurgitation III: Medical Management
508
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
508
Rheumatic Heart Disease III: Medical Management
469
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
469
Rheumatic Heart Disease IV: Nursing Management
426
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426


